“Alternative Approaches” to CBD from the FDA?
"So we're also interested in hearing from stakeholders and talking to Congress on possible alternative approaches; to make sure that we have an appropriately efficient and predictable regulatory framework for regulating CBD products."What are these alternative approaches? Roundtable counsel will be meeting with our friends in Congress to consider. Here’s our current position on CBD. When will the FDA discussions take place? Still unknown. Hemp champion Ryan Quarles, Kentucky’s Commissioner of Agriculture, pressed FDA officials for a timeline, but none was forthcoming. (Here’s a Facebook Live the Roundtable conducted with Commissioner Quarles after the meeting.) But it is clear that FDA is feeling the public pressure. "Since we put out that statement, since the farm bill passed, this is one of the top issues I'm being asked during my visits on Capitol Hill," Gottlieb told reporters. Let’s keep the pressure on – contact your Senators and Congressmen today and let them know you want a clear path to clear legal recognition of all hemp products, including CBD.

Take Action In Your State
Make Your Voice Heard
Track the latest hemp and CBD legislative developments in all 50 states and contact your elected representatives to demand action.
Go to the State Action Center